FDA Adverse Event Injury Summary report: N

PROLIEVE THERMODILITATION KIT

MDR report key: 1071616 · Received July 9, 2008

Report

Report Number
3005099803-2008-01103
Event Type
Injury
Date Received
July 9, 2008
Date of Event
June 6, 2008
Report Date
June 9, 2008
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
MEQ
PMA / PMN Number
P030006
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS IS NOT AVAILABLE, AND WE ARE NOT ABLE TO DETERMINE THE RELATIONSHIP BETWEEN THIS DEVICE AND THE CAUSE FOR THIS EVENT.

Description of Event or Problem · 1

NOTE: THIS REPORT PERTAINS TO THE FIRST OF TWO EVENTS THAT OCCURRED DURING THE SAME PROCEDURE. REFER TO ASSOCIATED MANUFACTURER REPORT 3005099803-2008-01102 FOR A DESCRIPTION OF THE SECOND EVENT. IN 2008, IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A MALE PATIENT UNDERWENT TREATMENT WITH A PROLIEVE THERMODILITATION KIT AS PART OF THE POST-MARKET STUDY USING PROLIEVE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH). REPORTEDLY, WHEN TRYING TO PLACE THE FIRST PROLIEVE CATHETER, THE PHYSICIAN HAD DIFFICULTY NAVIGATING THE S BEND. DURING THIS FIRST ATTEMPT, THE DEVICE BECAME SO BLOODIED THE PHYSICIAN WAS UNABLE TO USE IT. AS THE PHYSICIAN WAS TRYING TO PLACE THE SECOND PROLIEVE CATHETER, A FALSE CHANNEL DEVELOPED AND THE PHYSICIAN ABORTED THE CASE. NEXT, THE PHYSICIAN TRIED TO PLACE A FOLEY CATHETER (UNKNOWN MANUFACTURER) BUT BECAUSE THE PATIENT WAS BLEEDING SO MUCH; HE WAS UNABLE TO PLACE THE DEVICE. THE PATIENT WAS TAKEN TO THE AMBULATORY SURGERY CENTER AND TREATED. THE PATIENT WAS SCOPED AND HAD A COUNCIL TIP CATHETER PLACED (UNKNOWN MANUFACTURER). ACCORDING TO THE COMPLAINANT, THE PATIENT EXPERIENCED ADDITIONAL SYMPTOMS: HYPERTENSION, BLEEDING FROM THE BULBAR URETHRA, BLADDER SPASMS. THE PATIENT WAS TREATED FOR THESE SYMPTOMS AND THE FALSE CHANNEL WITH THE FOLLOWING CONCOMITANT MEDICATIONS: LABETALOL, LEVAQUIN, DIAZEPAM, TYLENOL, GENTAMICIN, LIDOCAINE, AND KETOROLAC. HYPERTENSION, COMMENCED ON THREE DAYS PRIOR TO ORIGINAL DATE, AND WAS RESOLVED ON THE SAME DAY. PUNCTURED HOLE IN URETHRA (FALSE CHANNEL), COMMENCED ON THE SAME DAY, AND WAS RESOLVED ON THIRTEEN DAYS LATER. BLEEDING FROM BULBAR URETHRA, COMMENCED ON THREE DAYS PRIOR TO ORIGINAL DATE, AND WAS RESOLVED ON THREE DAYS LATER. BLADDER SPASMS, COMMENCED ON THREE DAYS PRIOR TO ORIGINAL DATE, AND WAS RESOLVED ON THREE DAYS LATER. SUBSEQUENTLY, THE COUNCIL TIP CATHETER WAS REMOVED ON THE SAME DAY, AND THE PATIENT'S CONDITION WAS REPORTED AS "FINE".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PROLIEVE THERMODILITATION KIT MEQ BOSTON SCIENTIFIC CORPORATION M0068808022 0000605787

Patients

Seq Age Sex Outcome Treatment
1 58 YR Other